ANG Lifesciences

27.69
-0.02
(-0.07%)
ann
There are 2 new updates from the company22 hours ago
Viewcross
right
Market Cap
36.17 Cr
EPS
-7.65
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
62.75
52 Week Low
21.03
PB Ratio
0.51
Debt to Equity
0.88
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,785.00
#1 4,28,281.29
36.71
#1 49,887.20
12.06
#1 9,648
13.77
62.28
6,043.00
1,60,422.66
79.83
8,184.00
0.89
1,600
#1 64.53
65.97
1,526.00
1,23,242.04
25.11
26,520.70
14.17
4,155
47.38
63.02
3,226.30
1,09,192.65
60.42
10,785.70
11.59
1,656
13.54
62.35
2,560.00
1,05,620.10
52.60
10,615.60
19.57
1,942
-16.38
64.60
1,170.00
97,631.28
#1 18.66
28,905.40
12.36
5,578
1.69
61.75
2,031.80
92,759.99
33.50
20,141.50
#1 19.94
1,936
38.82
57.87
860.15
86,551.22
19.53
19,831.50
13.82
3,831
29.92
51.06
1,214.40
70,532.55
20.72
29,559.20
17.55
3,169
-10.04
65.79
29,720.00
63,152.93
47.82
6,097.20
10.80
1,201
16.01
49.09
Growth Rate
Revenue Growth
-36.06 %
Net Income Growth
3,266.67 %
Cash Flow Change
-135.97 %
ROE
4,333.33 %
ROCE
-98.01 %
EBITDA Margin (Avg.)
-32.15 %

Quarterly Financial Results

Quarterly Financials
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
32
36
120
90
50
96
74
60
47
49
57
34
19
38
20
33
25
Expenses
31
33
90
70
44
83
62
50
44
50
50
32
21
36
20
31
27
EBITDA
2
4
30
20
6
13
12
10
3
-1
7
2
-2
2
-0
3
-2
Operating Profit %
5 %
9 %
25 %
22 %
11 %
13 %
16 %
16 %
6 %
-26 %
12 %
5 %
-10 %
4 %
-9 %
7 %
-9 %
Depreciation
0
0
1
1
2
3
2
2
2
3
2
2
2
2
2
2
2
Interest
1
1
1
2
2
4
3
3
4
2
2
2
3
4
2
2
2
Profit Before Tax
1
2
28
17
2
7
7
4
-3
-6
2
-3
-6
-4
-4
-1
-6
Tax
0
1
8
4
1
2
3
2
-1
-1
1
-0
-0
-0
-1
1
-1
Net Profit
0
1
20
13
1
5
4
3
-2
-5
2
-2
-6
-4
-3
-2
-5
EPS in ₹
0.42
2.30
38.66
12.41
1.29
5.16
3.99
2.20
-1.36
-3.63
1.41
-1.74
-4.52
-2.75
-2.35
-1.53
-3.98

Balance Sheet

Balance Sheet
2022
2023
2024
Total Assets
291
278
242
Fixed Assets
93
88
58
Current Assets
193
183
173
Capital Work in Progress
0
0
0
Investments
0
0
0
Other Assets
198
190
184
Total Liabilities
291
278
242
Current Liabilities
166
162
145
Non Current Liabilities
41
29
22
Total Equity
84
86
76
Reserve & Surplus
69
69
59
Share Capital
10
13
13

Cash Flow

Cash Flow
2022
2023
2024
Net Cash Flow
0
0
0
Investing Activities
-44
-9
20
Operating Activities
25
26
-10
Financing Activities
20
-17
-10

Share Holding

% Holding
Mar 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
71.01 %
71.07 %
71.09 %
71.14 %
71.15 %
71.15 %
71.15 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
19.94 %
25.53 %
26.62 %
25.87 %
25.66 %
25.76 %
25.56 %
26.13 %
26.23 %
26.09 %
25.29 %
25.62 %
25.48 %
25.45 %
25.92 %
26.11 %
Others
9.05 %
3.40 %
2.29 %
2.99 %
3.20 %
3.09 %
3.30 %
3.27 %
3.16 %
3.31 %
4.11 %
3.78 %
3.92 %
3.95 %
3.48 %
3.29 %
No of Share Holders
0
328
323
2,522
4,259
5,215
6,939
7,163
7,305
7,055
6,918
6,868
6,631
6,468
6,517
6,508

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 1 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 1.33 0.00 0.00 0.00

Corporate Action

Announcements

Disclosure Of Non-Applicability Of SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated 26Th November 2018- Fund Raising By Issuance Of Debt Securities By Large Corporate (LC) 22 hours ago
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A22 hours ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20182 days ago
Closure of Trading WindowApr 01, 2025
Closure of Trading WindowApr 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMar 20, 2025
Appointment of Company Secretary and Compliance OfficerMar 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 15, 2025
Integrated Filing (Financial)Feb 14, 2025
UNAUDITED FINANCIAL RESULTS FOR Q.E. 31-12-2024Feb 14, 2025
Board Meeting Outcome for Board Meeting Outcome For SUBMISSION OF UNAUDITED FINANCIAL RESULTS FOR Q.E. 31-12-2024Feb 14, 2025
Board Meeting Intimation for Board Meeting Intimation For Board Meeting Intimation For Declaring Unaudited Standalone & Consolidated Financial Results For The Quarter And Nine Months Ended December 31Feb 06, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 14, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerDec 16, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 16, 2024
Financial Results For Quarter And Half Year Ended 30.09.2024.Nov 14, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On 14.11.2024Nov 14, 2024
Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015Nov 07, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 15, 2024
Scrutinizer Report And Evoting Result For AGM 30.09.2024 Of ANG Lifesciences India LimitedOct 02, 2024
Disclosure under Regulation 30A of LODROct 01, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMOct 01, 2024
Closure of Trading WindowSep 25, 2024
Reg. 34 (1) Annual Report.Sep 07, 2024
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sSep 07, 2024
Book Closure For 18Th Annual General MeetingSep 07, 2024
Notice Of AGM For FY 2023-24Sep 07, 2024
Unaudited Standalone And Consolidated Financial Result For Quarter Ended As At 30.06.2024Aug 14, 2024
Board Meeting Outcome for Outcome Of Board Meeting Dated 14.08.2024Aug 14, 2024
Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsAug 14, 2024
Board Meeting Intimation for Notice Of Board Meeting Under Reg. 29Of SEBI (LODR), 2015Aug 07, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 17, 2024
Closure of Trading WindowJun 29, 2024
Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015.Jun 27, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 13, 2024
Announcement under Regulation 30 (LODR)-CessationJun 13, 2024
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2024
Financial Result For Quarter And Year Ended As At 31.03.2024May 30, 2024
Board Meeting Outcome for Outcome Of Board MeetingMay 30, 2024
Announcement under Regulation 30 (LODR)-Meeting UpdatesMay 27, 2024
Board Meeting Intimation for Approval Of Audited Financial Standalone And Consolidated Statements For Quarter And Year Ended 31.03.2024.May 24, 2024
Announcement under Regulation 30 (LODR)-Meeting UpdatesMay 13, 2024
Disclosure And Intimation Of Non-Applicability Of SEBI Circular No SEBI/HO/DDHS/Clr/P /2018/744 Dated November 26, 2018 With Respect To Fund Raising By Issuance Of Debt Securities By Large Entities.Apr 30, 2024
Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.Apr 30, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 20, 2024
Compliance Certificate For The Year Ended 31.03.2024Apr 20, 2024
Clarification On Price MovementApr 10, 2024
Clarification sought from ANG Lifesciences India LtdApr 09, 2024
Closure of Trading WindowMar 30, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 16, 2024

Technical Indicators

RSI(14)
Neutral
46.40
ATR(14)
Less Volatile
2.08
STOCH(9,6)
Neutral
47.56
STOCH RSI(14)
Neutral
77.39
MACD(12,26)
Bullish
0.48
ADX(14)
Strong Trend
28.12
UO(9)
Bearish
45.21
ROC(12)
Uptrend And Accelerating
5.40
WillR(14)
Neutral
-43.19